Taehyun Chung, MD
Colorectal Surgery (Proctology) · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 3
- Since medical school
- 28 years
- University of Chicago, Pritzker School of Medicine, 1998
Offices
3 locations · San Francisco Surgical · North East Medical Services
Hospitals listed: California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chung’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A104629 · Current
Licensed to practise in California · since 2008 · expires 2027-09-30 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Colon and Rectal Surgery - Colon and Rectal Surgery
- American Board of Surgery - Surgery
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$69,834
Medicare paid this office $69,834 for 222 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection of hemorrhoid | 33 | $12,643 | $294 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,339 | $155 |
| New patient visit (45+ min) | 30 | $4,295 | $143 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $4,121 | $206 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,527 | $71 |
See all 8 services
| Injection of hemorrhoid | 33 | $12,643 | $294 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,339 | $155 |
| New patient visit (45+ min) | 30 | $4,295 | $143 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $4,121 | $206 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,527 | $71 |
| New patient visit (30+ min) | 30 | $2,820 | $94 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $2,770 | $198 |
| Short return visit (20+ min) | 20 | $1,613 | $81 |
Procedures Medicare counted
| Colonoscopy | 65 | More than 69% of doctors who do this |
| Hernia repair - groin (open) | 1-10 | None |
| Hernia repair (minimally invasive) | 13 | More than 78% of doctors who do this |
| Removal of tissue | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of hemorrhoid | 23 | 38 | 32 | 58 | 41 | 43 |
| Biopsy of large bowel using a flexible endoscope | – | 13 | 25 | 21 | – | – |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | – | – | 19 | 13 | – | – |
| Repair of groin hernia using an endoscope | 11 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
222 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 14% · Women 46% · Also on Medicaid 48% · Health risk score 1.33. At or below the middle of the specialty; the typical colorectal surgery (proctology) clinician is at 1.44.
Conditions among them: High blood pressure 70% · Diabetes 32% · Chronic kidney disease 28% · Depression 23% · Cancer 19% · Coronary heart disease 18% · COPD 14% · Atrial fibrillation 13% · Heart failure 10% · Stroke 9% · Dementia 6%.
The office billed $195,910, Medicare allowed $89,573 and paid $69,834; for 366 services of 51 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 222 | 366 | 74 | 1.33 | $195,910 | $69,834 |
| 2023 | 226 | 411 | 74 | 1.27 | $228,553 | $84,229 |
| 2022 | 239 | 396 | 73 | 1.26 | $249,140 | $87,405 |
| 2021 | 200 | 327 | 73 | 1.30 | $208,690 | $65,969 |
| 2020 | 185 | 348 | 73 | 1.45 | $192,731 | $72,123 |
| 2019 | 192 | 376 | 75 | 1.72 | $216,762 | $85,578 |
| 2018 | 238 | 518 | 74 | 1.61 | $246,162 | $92,575 |
| 2017 | 225 | 467 | 74 | 1.72 | $241,556 | $90,861 |
| 2016 | 226 | 481 | 74 | 1.54 | $274,788 | $100,577 |
| 2015 | 244 | 478 | 73 | 1.52 | $256,762 | $100,571 |
| 2014 | 244 | 467 | 74 | 1.39 | $303,910 | $114,072 |
| 2013 | 242 | 485 | 73 | 1.70 | $255,567 | $97,035 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Injection of hemorrhoid | 33 | $11,881 | $290 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,128 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $4,490 | $70 |
| New patient visit (45+ min) | 27 | $3,863 | $143 |
| Return visit (30+ min) | 24 | $2,522 | $97 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,434 | $203 |
| Short return visit (20+ min) | 23 | $2,052 | $79 |
| New patient visit (30+ min) | 14 | $1,163 | $83 |
2022: 11 services
| Injection of hemorrhoid | 40 | $17,227 | $297 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,084 | $157 |
| New patient visit (45+ min) | 32 | $3,987 | $125 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,659 | $205 |
| Biopsy of large bowel using a flexible endoscope | 21 | $2,366 | $113 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,266 | $206 |
| New patient visit (30+ min) | 24 | $2,183 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,124 | $62 |
| Short return visit (20+ min) | 24 | $2,015 | $72 |
| Return visit (30+ min) | 16 | $1,905 | $112 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 13 | $1,638 | $126 |
2021: 9 services
| Injection of hemorrhoid | 22 | $10,080 | $315 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 19 | $3,201 | $168 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,059 | $170 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,932 | $209 |
| New patient visit (45+ min) | 18 | $2,670 | $148 |
| Biopsy of large bowel using a flexible endoscope | 25 | $2,424 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,085 | $61 |
| Short return visit (20+ min) | 27 | $1,970 | $73 |
| New patient visit (30+ min) | 13 | $1,159 | $89 |
2020: 7 services
| Injection of hemorrhoid | 28 | $11,027 | $290 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,532 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $3,639 | $66 |
| New patient visit (30+ min) | 40 | $3,201 | $80 |
| Short return visit (20+ min) | 27 | $2,148 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,509 | $126 |
| Biopsy of large bowel using a flexible endoscope | 13 | $1,329 | $102 |
2019: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $7,105 | $182 |
| Injection of hemorrhoid | 17 | $6,046 | $263 |
| New patient visit (30+ min) | 61 | $5,673 | $93 |
| Repair of groin hernia using an endoscope | 11 | $4,661 | $424 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $4,128 | $66 |
| Short return visit (20+ min) | 33 | $2,222 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,720 | $123 |
2018: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $7,503 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $6,958 | $178 |
| Short return visit (20+ min) | 48 | $4,104 | $62 |
| New patient visit (30+ min) | 45 | $3,968 | $88 |
| Injection of hemorrhoid | 19 | $3,354 | $168 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,857 | $114 |
| Short return visit | 13 | $755 | $38 |
2017: 9 services
| Removal of gallbladder using an endoscope | 16 | $7,338 | $459 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $6,296 | $170 |
| Injection of hemorrhoid | 19 | $5,134 | $183 |
| New patient visit (30+ min) | 48 | $4,460 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $4,330 | $63 |
| Short return visit (20+ min) | 43 | $3,523 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,793 | $120 |
| Short return visit | 12 | $801 | $42 |
| Partial release of large bowel and partial removal of large bowel using an endoscope | 12 | $451 | $38 |
2016: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,410 | $180 |
| New patient visit (30+ min) | 56 | $5,408 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $5,240 | $65 |
| Short return visit (20+ min) | 46 | $4,178 | $65 |
| Injection of hemorrhoid | 15 | $2,912 | $171 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,834 | $122 |
| Short return visit | 17 | $1,228 | $41 |
2015: 8 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,490 | $178 |
| Injection of hemorrhoid | 21 | $6,398 | $237 |
| New patient visit (30+ min) | 57 | $5,442 | $95 |
| Removal of gallbladder using an endoscope | 15 | $5,347 | $356 |
| Short return visit (20+ min) | 48 | $4,174 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $3,987 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,726 | $115 |
| Short return visit | 14 | $1,712 | $42 |
2014: 7 services
| Removal of gallbladder using an endoscope | 17 | $7,437 | $437 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $4,865 | $113 |
| New patient visit (30+ min) | 56 | $4,811 | $86 |
| Injection of hemorrhoid | 18 | $4,555 | $240 |
| Short return visit (20+ min) | 52 | $4,114 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,696 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $2,573 | $64 |
2013: 7 services
| Injection of hemorrhoid | 25 | $7,338 | $237 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $5,570 | $90 |
| New patient visit (30+ min) | 64 | $4,960 | $78 |
| Short return visit (20+ min) | 53 | $4,942 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $4,120 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,872 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,146 | $165 |
Medicaid work
$36,556 in 2024
Medicaid paid $36,556 for 511 billed services this clinician did in 2024, up to 33 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 214 | $36,264 |
| Return visit (30+ min) | 27 | $169 |
| Short return visit (20+ min) | 270 | $123 |
| 2024 | 511 | 3 | 33 | $36,556 |
| 2023 | 239 | 3 | 25 | $20,336 |
| 2022 | 199 | 4 | 21 | $12,745 |
| 2021 | 545 | 4 | 26 | $36,047 |
| 2020 | 247 | 4 | 25 | $16,274 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 133 | $20,304 |
| Return visit (30+ min) | 53 | $32 |
| Short return visit (20+ min) | 53 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 80 | $12,745 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 12 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 37 | $0 |
| Return visit (30+ min) | 70 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 171 | $36,047 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 53 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 92 | $0 |
| Return visit (30+ min) | 229 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 96 | $16,233 |
| Short return visit (20+ min) | 80 | $41 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 30 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 41 | $0 |
Drugs they prescribed that Part D paid
$8,530
Pharmacies billed $8,530 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 13% of their Part D prescriptions (26 of 204) in 2024. At or below the middle of the specialty; the typical colorectal surgery (proctology) clinician is at 16%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
140 generic and 64 brand-name prescriptions · $8,530 in drug cost · 15 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Sod Sulf-Potass Sulf-Mag Sulf | 81 | $4,594 | $55 |
| Suprep | 24 | $2,488 | $100 |
| Hydrocodone-Acetaminophen | 16 | $110 | $7 |
| Ibuprofen | 22 | $61 | $2 |
Year by year
| 2024 | 204 | 158 | 13% (26) | 31% | $8,530 |
| 2023 | 186 | 112 | 16% (30) | 23% | $8,727 |
| 2022 | 206 | 101 | 20% (42) | 24% | $8,435 |
| 2021 | 137 | 104 | 18% (24) | 63% | $9,567 |
| 2020 | 105 | 62 | 31% (33) | 30% | $3,891 |
| 2019 | 120 | 69 | 36% (43) | 25% | $6,311 |
| 2018 | 148 | 73 | 34% (50) | 16% | $4,180 |
| 2017 | 137 | 65 | 35% (48) | 11% | $3,860 |
| 2016 | 141 | 62 | 33% (46) | 18% | $6,008 |
| 2015 | 142 | 69 | 40% (57) | 12% | $4,114 |
| 2014 | 142 | 72 | 62% (88) | 9% | $3,053 |
| 2013 | 108 | 72 | 36% (39) | 23% | $3,967 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Sod Sulf-Potass Sulf-Mag Sulf | 32 | $2,438 | $76 |
| Sutab | 14 | $2,314 | $165 |
| Gavilyte-G | 19 | $333 | $18 |
| Ibuprofen | 27 | $154 | $6 |
| Hydrocodone-Acetaminophen | 16 | $105 | $7 |
| Neomycin Sulfate | 13 | $88 | $7 |
| Metronidazole | 13 | $22 | $2 |
2022: 5 drugs
| Suprep | 29 | $3,410 | $118 |
| Hydrocodone-Acetaminophen | 33 | $269 | $8 |
| Ibuprofen | 37 | $174 | $5 |
| Metronidazole | 19 | $92 | $5 |
| Neomycin Sulfate | 15 | $78 | $5 |
2021: 3 drugs
| Suprep | 84 | $9,259 | $110 |
| Hydrocodone-Acetaminophen | 17 | $118 | $7 |
| Ibuprofen | 15 | $52 | $3 |
2020: 3 drugs
| Suprep | 30 | $3,152 | $105 |
| Hydrocodone-Acetaminophen | 21 | $149 | $7 |
| Ibuprofen | 12 | $35 | $3 |
2019: 3 drugs
| Suprep | 21 | $2,073 | $99 |
| Hydrocodone-Acetaminophen | 31 | $209 | $7 |
| Ibuprofen | 15 | $77 | $5 |
2018: 2 drugs
| Suprep | 20 | $1,883 | $94 |
| Hydrocodone-Acetaminophen | 29 | $288 | $10 |
2017: 4 drugs
| Suprep | 14 | $1,237 | $88 |
| Oxycodone-Acetaminophen | 18 | $882 | $49 |
| Hydrocodone-Acetaminophen | 25 | $342 | $14 |
| Metronidazole | 14 | $92 | $7 |
2016: 5 drugs
| Suprep | 23 | $1,916 | $83 |
| Lidocaine | 12 | $1,722 | $143 |
| Oxycodone-Acetaminophen | 11 | $724 | $66 |
| Hydrocodone-Acetaminophen | 32 | $650 | $20 |
| Metronidazole | 11 | $41 | $4 |
2015: 2 drugs
| Suprep | 13 | $1,048 | $81 |
| Hydrocodone-Acetaminophen | 39 | $719 | $18 |
2014: 1 drug
| Hydrocodone-Acetaminophen | 75 | $843 | $11 |
2013: 2 drugs
| Suprep | 18 | $1,288 | $72 |
| Hydrocodone-Acetaminophen | 34 | $406 | $12 |
Money from drug and device companies
$149 in 2025
| 2025 | 6 | 6 | None | $149 |
| 2023 | 3 | 3 | None | $53 |
| 2022 | 4 | 4 | None | $81 |
| 2021 | 1 | 1 | None | $23 |
| 2020 | 1 | 1 | None | $19 |
| 2019 | 2 | 2 | None | $230 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Takeda Pharmaceuticals U.S.A. | Entyvio | $35 | 1 payment
|
| Ethicon US | Harmonic | $30 | 1 payment
|
| Phathom Pharmaceuticals | Voquezna | $27 | 1 payment
|
| Ethicon | None | $22 | 1 payment
|
| Stimlabs | Corplex P | $19 | 1 payment
|
| Ipsen Biopharmaceuticals | Iqirvo | $16 | 1 payment
|
See all 6 published payments
| Phathom Pharmaceuticals | Meals · 2025-12-15 | Voquezna | $27 |
| Ipsen Biopharmaceuticals | Meals · 2025-08-27 | Iqirvo | $16 |
| Stimlabs | Meals · 2025-07-23 | Corplex P | $19 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-12 | Entyvio | $35 |
| Ethicon | Meals · 2025-05-07 | None | $22 |
| Ethicon US | Meals · 2025-04-29 | Harmonic | $30 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $53
| Ethicon US | Echelon; Endopath | $22 | 1 payment
|
| Innocoll Pharmaceuticals | Xaracoll | $16 | 1 payment
|
| Pacira Pharmaceuticals | Exparel | $15 | 1 payment
|
2022: $81
| Merck Sharp & Dohme | None | $24 | 1 payment
|
| Boston Scientific | Exalt Model D | $22 | 1 payment
|
| Davol | Phasix Mesh | $19 | 1 payment
|
| Innocoll Pharmaceuticals | Xaracoll | $16 | 1 payment
|
2021: $23
| Medtronic | Eea | $23 | 1 payment
|
2020: $19
| Davol | Phasix | $19 | 1 payment
|
2019: $230
| Intuitive Surgical | Da Vinci Surgical System | $209 | 1 payment
|
| Braintree Laboratories | Suprep Bowel Prep | $21 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1821170150
- Licence
- CA A104629California A104629: Current · expires 2027-09-30
- Trained
- University of Chicago, Pritzker School of Medicine, 1998 · 28 years ago
- Group
- San Francisco Surgical · North East Medical Services
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208C00000X (208C00000X); Surgery (208600000X)
- Mailing address
- 3838 California St, Suite 616, San Francisco, CA, 94118
- NPI first listed
- 2006-10-19
- NPI last updated
- 2013-07-31
This is when the NPI record was last certified, not a medical board exam.